Danish neuroscientist sentenced by court for lying about faked experiments

court caseIn a rare development, neuroscientist Milena Penkowa has been sentenced by a Danish court for faking data.

The ruling, from the Copenhagen City Court, resulted from Penkowa’s publication of her 2003 thesis describing experiments that she never carried out. The court “placed weight” on the fact that she didn’t just commit fraud, but “systematically supplied false information” to avoid being caught, according to the court’s notice.

The sentence is nine months of “conditional imprisonment,” according to our translation; The University Posta newspaper affiliated with the University of Copenhagen, calls it a “nine month suspended sentence with a two years probation.”

Here’s the full summary of the new ruling, from the Copenhagen City Court (translated from Danish by One Hour Translation):

Continue reading Danish neuroscientist sentenced by court for lying about faked experiments

German dep’t head reprimanded for not catching mistakes of co-author Lichtenthaler

Holger Ernst
Holger Ernst

The head of a department at WHU — Otto Beisheim School of Management has been charged with “severe scientific misconduct” for not spotting many of the data irregularities of his co-author Ulrich Lichtenthaler, which have ultimately led to 16 retractions.

According to a news release describing a WHU investigation (which we had translated using One Hour Translation), Holger Ernst did not neglect his supervisory duties, but, as a co-author on many of the retracted papers, he should have been more aware of the data issues in Lichtenthaler’s work: Continue reading German dep’t head reprimanded for not catching mistakes of co-author Lichtenthaler

“Fabricated results” retract JAMA clinical trial, plus a sub-analysis of the data

Screen Shot 2015-09-14 at 11.00.11 AMA JAMA clinical trial that suggested a blood pressure drug could help patients increase their physical fitness, and a sub-analysis of those data, have been retracted after “an admission of fabricated results” by the first author on both papers.

The three-year clinical trial was published in JAMA in 2013.  It was retracted this morning.

The trial found ramipril helped patients with artery disease walk longer and with less pain, according to the abstract:

Among patients with intermittent claudication, 24-week treatment with ramipril resulted in significant increases in pain-free and maximum treadmill walking times compared with placebo. This was associated with a significant increase in the physical functioning component of the SF-36 score.

The retraction note explains how the fabricated data came to light: 

Continue reading “Fabricated results” retract JAMA clinical trial, plus a sub-analysis of the data

Weekend reads: Backstabbing; plagiarism irony; preprints to the rescue

booksThe week at Retraction Watch featured a call for the retraction of a paper in NEJM, and a withdrawal of a paper because authors couldn’t pay the page charges. Here’s what was happening elsewhere: Continue reading Weekend reads: Backstabbing; plagiarism irony; preprints to the rescue

Former accounting prof adds his 32nd retraction

james-hunton
James Hunton

Another retraction makes 32.5 for former accounting professor James E. Hunton, and earns him the #10 slot on our leaderboard.

Though he resigned from his position at Bentley University in 2012, the story didn’t end there: In 2014, a university investigation found he’d committed misconduct in two papers. The, in June 2015, he notched 25 retractions all at once.

The newly retracted paper, “Effects of Anonymous Whistle- Blowing and Perceived Reputation Threats on Investigations of Whistle-Blowing Allegations by Audit Committee Members,” published in the Journal of Management Studies, suggests that, for public corporations, an anonymous whistleblower might not be as effective as an alert from a known source. The publisher Wiley put out a press release for the paper in 2010, and it succeeded in garnering some coverage.

Whether its conclusion remains valid is unclear, as Hunton didn’t provide evidence to support the validity of the data. The note explains:

Continue reading Former accounting prof adds his 32nd retraction

5th retraction for Voinnet follows correction, EoC to PLOS Genetics paper

PLOS GeneticsAfter correcting a paper due to problematic figure panels, researchers led by high-profile biologist Olivier Voinnet have now retracted it, after “further analysis of the paper revealed flaws in the interpretation of” another figure.

PLOS Genetics published the retraction notice September 3 for the 2013 paper on the molecular details of embryonic stem cells in mice. First author Constance Ciaudo and Voinnet assume “full responsibility for the mistakes on this paper,” according to the note.

Continue reading 5th retraction for Voinnet follows correction, EoC to PLOS Genetics paper

“Whoops.” Paper cites retracted gay canvassing paper — but blame me, says journal editor

arch sex behavBy now, most Retraction Watch readers are likely familiar with the retraction in May of a much-ballyhooed study in Science on whether gay canvassers could persuade people to agree with same-sex marriage. It turns out that before that retraction appeared, a different study that cited the Science paper made its way online.

Kenneth Zucker, the editor of Archives of Sexual Behavior, which published the study online in February, 2015, decided he had some ‘splaining to do. The article has now been published as the lead paper in the current issue of the journal, which also includes a comment from Zucker. He explains what happened: Continue reading “Whoops.” Paper cites retracted gay canvassing paper — but blame me, says journal editor

Stem cell researcher Jacob Hanna’s correction count updated to 10

Jacob Hanna
Jacob Hanna

Thanks to some eagle-eyed readers, we’ve been alerted to some corrections for high profile stem cell scientist Jacob Hanna that we had missed, bringing our count to one retraction and 13 errata on 10 papers.

The problems in the work range from duplications of images, to inadvertent deletions in figures, to failures by his co-authors to disclose funding sources or conflicts of interest. Hanna is the first or last author on 4 of the papers, and one of several on the rest.

First up, a correction to a Cell paper on which Hanna is the first author:

Continue reading Stem cell researcher Jacob Hanna’s correction count updated to 10

Investigation of prominent geneticist Latchman finds “procedural matters,” no misconduct

David Latchman, Birkbeck

An investigation by the University College London has cleared prominent geneticist David Latchman of misconduct, but concluded he has “procedural matters in his lab that required attention.”

Latchman has two retracted paperson PubPeer, there are questions about nearly four dozen more.

The results of the investigation were first reported by the Times Higher Education. We also received a short statement from a UCL spokesperson:

Continue reading Investigation of prominent geneticist Latchman finds “procedural matters,” no misconduct

Trachea surgeon Macchiarini acted “without due care,” but is not guilty of misconduct: Karolinska

Paolo Macchiarini
Paolo Macchiarini

Following an investigation, Karolinska Institutet has found that surgeon and visiting professor Paolo Macchiarini acted in some cases “without due care,” but that his behavior “does not qualify as scientific misconduct.”

Karolinska’s Vice Chancellor has also recommended that Macchiarini submit an unspecified number of corrections “to clarify and rectify the failings that the inquiry has brought to light.”

Macchiarini is most well-known for pioneering the creation of tracheas from cadavers and patients’ own stem cells. However, the glow of his success was diminished somewhat after four Karolinska surgeons filed a complaint, alleging Macchiarini had downplayed the risks of the procedure and not obtained proper consent, among other accusations.

An external review by Bengt Gerdin of Uppsala University concluded in May that Continue reading Trachea surgeon Macchiarini acted “without due care,” but is not guilty of misconduct: Karolinska